Novel motif:86: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Novel_motif
|name=motif86_CGCACAGACCGCGC
|novel_motifs_human_sample_pval=11376-118A8_11051;0.604094,11327-117E4_11969;0.481936,11473-119C6_11054;0.413971,11474-119C7_12067...") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:59, 9 September 2013
name: | motif86_CGCACAGACCGCGC |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 1.326599e-26 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 2.618051e-26 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 5.870595e-23 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 5.357956e-22 |
GO:0031017 | exocrine pancreas development | 7.008664e-17 |
GO:0006349 | regulation of gene expression by genetic imprinting | 5.053807e-14 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 1.363372e-13 |
GO:0006369 | termination of RNA polymerase II transcription | 1.122141e-11 |
GO:0071514 | genetic imprinting | 2.070330e-11 |
GO:0006268 | DNA unwinding involved in replication | 8.025366e-10 |
GO:0035470 | positive regulation of vascular wound healing | 2.140538e-9 |
GO:0045725 | positive regulation of glycogen biosynthetic process | 7.379060e-9 |
GO:0005979 | regulation of glycogen biosynthetic process | 1.058062e-8 |
GO:0097039 | protein linear polyubiquitination | 1.746870e-8 |
GO:0070873 | regulation of glycogen metabolic process | 5.607863e-8 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 5.762736e-8 |
GO:0006353 | transcription termination, DNA-dependent | 6.065834e-8 |
GO:0031848 | protection from non-homologous end joining at telomere | 6.111019e-8 |
GO:0070875 | positive regulation of glycogen metabolic process | 6.137997e-8 |
GO:0035329 | hippo signaling cascade | 1.021382e-7 |
GO:2000273 | positive regulation of receptor activity | 1.913123e-7 |
GO:0006117 | acetaldehyde metabolic process | 1.965797e-7 |
GO:0033590 | response to cobalamin | 1.965797e-7 |
GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific | 6.044116e-7 |
GO:0051586 | positive regulation of dopamine uptake | 8.821612e-7 |
GO:0051324 | prophase | 1.003883e-6 |
GO:0043249 | erythrocyte maturation | 1.211988e-6 |
GO:0050434 | positive regulation of viral transcription | 1.215956e-6 |
GO:0043174 | nucleoside salvage | 1.286893e-6 |
GO:0006400 | tRNA modification | 1.399836e-6 |
GO:0042703 | menstruation | 1.823022e-6 |
GO:0019101 | female somatic sex determination | 1.823022e-6 |
GO:0006406 | mRNA export from nucleus | 1.907208e-6 |
GO:0030579 | ubiquitin-dependent SMAD protein catabolic process | 2.440290e-6 |
GO:0048102 | autophagic cell death | 2.576825e-6 |
GO:0060976 | coronary vasculature development | 3.230556e-6 |
GO:0008286 | insulin receptor signaling pathway | 3.453634e-6 |
GO:0006398 | histone mRNA 3'-end processing | 4.258833e-6 |
GO:0051645 | Golgi localization | 4.678822e-6 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 5.222793e-6 |
GO:0048050 | post-embryonic eye morphogenesis | 5.222793e-6 |
GO:0001522 | pseudouridine synthesis | 8.433849e-6 |
GO:0000239 | pachytene | 9.643670e-6 |
GO:0046886 | positive regulation of hormone biosynthetic process | 9.853630e-6 |
GO:0002074 | extraocular skeletal muscle development | 9.865553e-6 |
GO:0008334 | histone mRNA metabolic process | 1.262086e-5 |
GO:0006220 | pyrimidine nucleotide metabolic process | 1.411547e-5 |
GO:0046604 | positive regulation of mitotic centrosome separation | 1.646193e-5 |
GO:0000413 | protein peptidyl-prolyl isomerization | 1.652474e-5 |
GO:0016233 | telomere capping | 1.966265e-5 |
GO:0072178 | nephric duct morphogenesis | 1.982376e-5 |
GO:0035419 | activation of MAPK activity involved in innate immune response | 2.021277e-5 |
GO:0043097 | pyrimidine nucleoside salvage | 2.068033e-5 |
GO:0072176 | nephric duct development | 2.285030e-5 |
GO:0006405 | RNA export from nucleus | 2.347300e-5 |
GO:0007035 | vacuolar acidification | 2.381095e-5 |
GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 2.567292e-5 |
GO:0032352 | positive regulation of hormone metabolic process | 2.755097e-5 |
GO:0042149 | cellular response to glucose starvation | 2.875033e-5 |
GO:0006298 | mismatch repair | 2.923088e-5 |
GO:0030237 | female sex determination | 2.924142e-5 |
GO:0008033 | tRNA processing | 2.978314e-5 |
GO:0050668 | positive regulation of homocysteine metabolic process | 3.036680e-5 |
GO:0045963 | negative regulation of dopamine metabolic process | 3.036680e-5 |
GO:0001710 | mesodermal cell fate commitment | 3.498458e-5 |
GO:0007128 | meiotic prophase I | 3.739633e-5 |
GO:0061360 | optic chiasma development | 3.808947e-5 |
GO:2000597 | positive regulation of optic nerve formation | 3.808947e-5 |
GO:0021650 | vestibulocochlear nerve formation | 3.808947e-5 |
GO:0035799 | ureter maturation | 3.808947e-5 |
GO:0021633 | optic nerve structural organization | 3.808947e-5 |
GO:0071353 | cellular response to interleukin-4 | 3.890906e-5 |
GO:0045217 | cell-cell junction maintenance | 4.105758e-5 |
GO:0006548 | histidine catabolic process | 4.134546e-5 |
GO:0018993 | somatic sex determination | 4.265712e-5 |
GO:0003406 | retinal pigment epithelium development | 4.285552e-5 |
GO:0006261 | DNA-dependent DNA replication | 4.330627e-5 |
GO:0006348 | chromatin silencing at telomere | 4.495859e-5 |
GO:0042104 | positive regulation of activated T cell proliferation | 4.524376e-5 |
GO:0009451 | RNA modification | 4.735112e-5 |
GO:0014037 | Schwann cell differentiation | 4.872770e-5 |
GO:0072298 | regulation of metanephric glomerulus development | 5.284345e-5 |
GO:0043467 | regulation of generation of precursor metabolites and energy | 5.401231e-5 |
GO:0014040 | positive regulation of Schwann cell differentiation | 5.523147e-5 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 5.523147e-5 |
GO:0048561 | establishment of organ orientation | 5.841048e-5 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 5.949184e-5 |
GO:0010893 | positive regulation of steroid biosynthetic process | 5.972837e-5 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 5.978505e-5 |
GO:0007212 | dopamine receptor signaling pathway | 7.249995e-5 |
GO:0033233 | regulation of protein sumoylation | 7.392997e-5 |
GO:0042069 | regulation of catecholamine metabolic process | 7.765666e-5 |
GO:0046607 | positive regulation of centrosome cycle | 7.961375e-5 |
GO:0006529 | asparagine biosynthetic process | 7.961375e-5 |
GO:0009265 | 2'-deoxyribonucleotide biosynthetic process | 8.587173e-5 |
GO:0001510 | RNA methylation | 8.601746e-5 |
GO:0000244 | assembly of spliceosomal tri-snRNP | 8.666273e-5 |
GO:0046782 | regulation of viral transcription | 8.802512e-5 |
GO:0070534 | protein K63-linked ubiquitination | 1.088747e-4 |
GO:0061157 | mRNA destabilization | 1.122074e-4 |
GO:0010609 | posttranscriptional regulation of gene expression by mRNA localization | 1.122074e-4 |
GO:0042421 | norepinephrine biosynthetic process | 1.217510e-4 |
GO:0009304 | tRNA transcription | 1.253714e-4 |
GO:0021528 | commissural neuron differentiation in spinal cord | 1.263667e-4 |
GO:0007020 | microtubule nucleation | 1.266061e-4 |
GO:0051567 | histone H3-K9 methylation | 1.291023e-4 |
GO:0050666 | regulation of homocysteine metabolic process | 1.399515e-4 |
GO:0030488 | tRNA methylation | 1.399515e-4 |
GO:0072300 | positive regulation of metanephric glomerulus development | 1.425575e-4 |
GO:2000703 | negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation | 1.446742e-4 |
GO:2000734 | negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation | 1.446742e-4 |
GO:2000667 | positive regulation of interleukin-13 secretion | 1.446742e-4 |
GO:2000662 | regulation of interleukin-5 secretion | 1.446742e-4 |
GO:2000665 | regulation of interleukin-13 secretion | 1.446742e-4 |
GO:2000607 | negative regulation of cell proliferation involved in mesonephros development | 1.446742e-4 |
GO:2000664 | positive regulation of interleukin-5 secretion | 1.446742e-4 |
GO:0048255 | mRNA stabilization | 1.449720e-4 |
GO:0090324 | negative regulation of oxidative phosphorylation | 1.490124e-4 |
GO:0010255 | glucose mediated signaling pathway | 1.490124e-4 |
GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process | 1.561904e-4 |
GO:0072528 | pyrimidine-containing compound biosynthetic process | 1.586388e-4 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 1.586428e-4 |
GO:0072107 | positive regulation of ureteric bud formation | 1.707049e-4 |
GO:0006270 | DNA-dependent DNA replication initiation | 1.714153e-4 |
GO:0043503 | skeletal muscle fiber adaptation | 1.812096e-4 |
GO:0071956 | cellular component maintenance at cellular level | 1.854845e-4 |
GO:0060160 | negative regulation of dopamine receptor signaling pathway | 1.889711e-4 |
GO:0033235 | positive regulation of protein sumoylation | 1.892359e-4 |
GO:0070979 | protein K11-linked ubiquitination | 1.968561e-4 |
GO:0018208 | peptidyl-proline modification | 2.035882e-4 |
GO:0031627 | telomeric loop formation | 2.066150e-4 |
GO:0009186 | deoxyribonucleoside diphosphate metabolic process | 2.288896e-4 |
GO:2000466 | negative regulation of glycogen (starch) synthase activity | 2.290429e-4 |
GO:0043923 | positive regulation by host of viral transcription | 2.292938e-4 |
GO:0021562 | vestibulocochlear nerve development | 2.501126e-4 |
GO:0009263 | deoxyribonucleotide biosynthetic process | 2.683039e-4 |
GO:0060564 | negative regulation of mitotic anaphase-promoting complex activity | 2.720061e-4 |
GO:0042053 | regulation of dopamine metabolic process | 3.112474e-4 |
GO:0035566 | regulation of metanephros size | 3.168478e-4 |
GO:0070926 | regulation of ATP:ADP antiporter activity | 3.307662e-4 |
GO:0072179 | nephric duct formation | 3.448095e-4 |
GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | 3.461788e-4 |
GO:0003329 | pancreatic PP cell fate commitment | 3.461788e-4 |
GO:0003326 | pancreatic A cell fate commitment | 3.461788e-4 |
GO:0060179 | male mating behavior | 3.591642e-4 |
GO:2001037 | positive regulation of tongue muscle cell differentiation | 3.682663e-4 |
GO:0001830 | trophectodermal cell fate commitment | 3.682663e-4 |
GO:0097152 | mesenchymal cell apoptosis | 3.682663e-4 |
GO:0002438 | acute inflammatory response to antigenic stimulus | 3.682663e-4 |
GO:0060982 | coronary artery morphogenesis | 3.682663e-4 |
GO:0045299 | otolith mineralization | 3.771029e-4 |
GO:0006359 | regulation of transcription from RNA polymerase III promoter | 3.808643e-4 |
GO:0050861 | positive regulation of B cell receptor signaling pathway | 3.905852e-4 |
GO:0002635 | negative regulation of germinal center formation | 3.905852e-4 |
GO:0070670 | response to interleukin-4 | 3.970176e-4 |
GO:0042415 | norepinephrine metabolic process | 3.994971e-4 |
GO:0009405 | pathogenesis | 4.001341e-4 |
GO:0002693 | positive regulation of cellular extravasation | 4.448129e-4 |
GO:0046626 | regulation of insulin receptor signaling pathway | 4.659307e-4 |
GO:0043091 | L-arginine import | 4.661790e-4 |
GO:0070839 | divalent metal ion export | 4.661790e-4 |
GO:0045342 | MHC class II biosynthetic process | 4.661790e-4 |
GO:0032632 | interleukin-3 production | 4.661790e-4 |
GO:0006876 | cellular cadmium ion homeostasis | 4.661790e-4 |
GO:0015707 | nitrite transport | 4.661790e-4 |
GO:0060711 | labyrinthine layer development | 4.815123e-4 |
GO:0090344 | negative regulation of cell aging | 4.891735e-4 |
GO:0046006 | regulation of activated T cell proliferation | 4.951151e-4 |
GO:0007195 | inhibition of adenylate cyclase activity by dopamine receptor signaling pathway | 5.022539e-4 |
GO:0033342 | negative regulation of collagen binding | 5.299319e-4 |
GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change | 5.299319e-4 |
GO:0060023 | soft palate development | 6.118745e-4 |
GO:0002456 | T cell mediated immunity | 6.157571e-4 |
GO:2000251 | positive regulation of actin cytoskeleton reorganization | 6.217347e-4 |
GO:0032392 | DNA geometric change | 6.863946e-4 |
GO:0031365 | N-terminal protein amino acid modification | 6.946692e-4 |
GO:0043128 | positive regulation of 1-phosphatidylinositol 4-kinase activity | 7.082437e-4 |
GO:0048199 | vesicle targeting, to, from or within Golgi | 7.129129e-4 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 7.697839e-4 |
GO:0043973 | histone H3-K4 acetylation | 7.697839e-4 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 7.697839e-4 |
GO:0002536 | respiratory burst involved in inflammatory response | 7.697839e-4 |
GO:0006021 | inositol biosynthetic process | 7.966333e-4 |
GO:0014044 | Schwann cell development | 8.220331e-4 |
GO:0070537 | histone H2A K63-linked deubiquitination | 8.268846e-4 |
GO:0070947 | neutrophil mediated killing of fungus | 8.296532e-4 |
GO:0008355 | olfactory learning | 8.509645e-4 |
GO:0003360 | brainstem development | 8.509645e-4 |
GO:0035305 | negative regulation of dephosphorylation | 9.014880e-4 |
GO:0006901 | vesicle coating | 9.080203e-4 |
GO:0048752 | semicircular canal morphogenesis | 9.273824e-4 |
GO:0006308 | DNA catabolic process | 9.422492e-4 |
GO:0034969 | histone arginine methylation | 9.433711e-4 |
GO:0021526 | medial motor column neuron differentiation | 9.799573e-4 |
GO:0002309 | T cell proliferation involved in immune response | 9.799573e-4 |
GO:0030262 | apoptotic nuclear change | 1.004205e-3 |
GO:0034470 | ncRNA processing | 1.008060e-3 |
GO:0006013 | mannose metabolic process | 1.016687e-3 |
GO:0033007 | negative regulation of mast cell activation involved in immune response | 1.018690e-3 |
GO:0032508 | DNA duplex unwinding | 1.064055e-3 |
GO:0035036 | sperm-egg recognition | 1.080719e-3 |
GO:0014028 | notochord formation | 1.151448e-3 |
GO:0060014 | granulosa cell differentiation | 1.164702e-3 |
GO:2000209 | regulation of anoikis | 1.326909e-3 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 1.332004e-3 |
GO:0051882 | mitochondrial depolarization | 1.340544e-3 |
GO:0006258 | UDP-glucose catabolic process | 1.348793e-3 |
GO:0031860 | telomeric 3' overhang formation | 1.348793e-3 |
GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation | 1.348793e-3 |
GO:0071218 | cellular response to misfolded protein | 1.352682e-3 |
GO:0034770 | histone H4-K20 methylation | 1.485986e-3 |
GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions | 1.485986e-3 |
GO:0043491 | protein kinase B signaling cascade | 1.500375e-3 |
GO:0060977 | coronary vasculature morphogenesis | 1.508510e-3 |
GO:0071044 | histone mRNA catabolic process | 1.543348e-3 |
GO:0060375 | regulation of mast cell differentiation | 1.548388e-3 |
GO:0022007 | convergent extension involved in neural plate elongation | 1.548388e-3 |
GO:0048339 | paraxial mesoderm development | 1.586039e-3 |
GO:0045007 | depurination | 1.594354e-3 |
GO:0042407 | cristae formation | 1.607655e-3 |
GO:0008210 | estrogen metabolic process | 1.698700e-3 |
GO:0045065 | cytotoxic T cell differentiation | 1.699576e-3 |
GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process | 1.745349e-3 |
GO:0035522 | monoubiquitinated histone H2A deubiquitination | 1.760420e-3 |
GO:0060465 | pharynx development | 1.760420e-3 |
GO:0015887 | pantothenate transmembrane transport | 1.760420e-3 |
GO:0015878 | biotin transport | 1.760420e-3 |
GO:0002508 | central tolerance induction | 1.760420e-3 |
GO:0002897 | positive regulation of central B cell tolerance induction | 1.760420e-3 |
GO:0031914 | negative regulation of synaptic plasticity | 1.771723e-3 |
GO:0034401 | regulation of transcription by chromatin organization | 1.820558e-3 |
GO:0021586 | pons maturation | 1.823426e-3 |
GO:0006285 | base-excision repair, AP site formation | 1.839467e-3 |
GO:0043305 | negative regulation of mast cell degranulation | 1.907908e-3 |
GO:0055026 | negative regulation of cardiac muscle tissue development | 1.919724e-3 |
GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter | 1.955231e-3 |
GO:0046813 | virion attachment, binding of host cell surface receptor | 1.982206e-3 |
GO:0034214 | protein hexamerization | 1.982206e-3 |
GO:0010923 | negative regulation of phosphatase activity | 2.004821e-3 |
GO:0015693 | magnesium ion transport | 2.014007e-3 |
GO:0032506 | cytokinetic process | 2.097266e-3 |
GO:0048208 | COPII vesicle coating | 2.120065e-3 |
GO:0015804 | neutral amino acid transport | 2.167714e-3 |
GO:0032225 | regulation of synaptic transmission, dopaminergic | 2.203198e-3 |
GO:0050779 | RNA destabilization | 2.207005e-3 |
GO:0006515 | misfolded or incompletely synthesized protein catabolic process | 2.241532e-3 |
GO:0048484 | enteric nervous system development | 2.324853e-3 |
GO:0006221 | pyrimidine nucleotide biosynthetic process | 2.368047e-3 |
GO:0048341 | paraxial mesoderm formation | 2.395300e-3 |
GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus | 2.444102e-3 |
GO:0035090 | maintenance of apical/basal cell polarity | 2.444102e-3 |
GO:0006488 | dolichol-linked oligosaccharide biosynthetic process | 2.499050e-3 |
GO:0021819 | layer formation in cerebral cortex | 2.536165e-3 |
GO:0015709 | thiosulfate transport | 2.543457e-3 |
GO:0071423 | malate transmembrane transport | 2.543457e-3 |
GO:0006844 | acyl carnitine transport | 2.543457e-3 |
GO:0060683 | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling | 2.556265e-3 |
GO:0048846 | axon extension involved in axon guidance | 2.564487e-3 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 2.746505e-3 |
GO:0001823 | mesonephros development | 2.751507e-3 |
GO:0014038 | regulation of Schwann cell differentiation | 2.826825e-3 |
GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition | 2.870708e-3 |
GO:0060580 | ventral spinal cord interneuron fate determination | 2.870708e-3 |
GO:0046984 | regulation of hemoglobin biosynthetic process | 2.870708e-3 |
GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation | 2.870708e-3 |
GO:0006233 | dTDP biosynthetic process | 2.870708e-3 |
GO:0003327 | type B pancreatic cell fate commitment | 2.870708e-3 |
GO:0009138 | pyrimidine nucleoside diphosphate metabolic process | 3.099686e-3 |
GO:0006177 | GMP biosynthetic process | 3.292280e-3 |
GO:0006188 | IMP biosynthetic process | 3.295006e-3 |
GO:0003195 | tricuspid valve formation | 3.335919e-3 |
GO:0060377 | negative regulation of mast cell differentiation | 3.335919e-3 |
GO:0045403 | negative regulation of interleukin-4 biosynthetic process | 3.335919e-3 |
GO:0003192 | mitral valve formation | 3.335919e-3 |
GO:0002295 | T-helper cell lineage commitment | 3.335919e-3 |
GO:0002082 | regulation of oxidative phosphorylation | 3.335919e-3 |
GO:0051935 | glutamate uptake involved in synaptic transmission | 3.385314e-3 |
GO:0043301 | negative regulation of leukocyte degranulation | 3.421199e-3 |
GO:0050747 | positive regulation of lipoprotein metabolic process | 3.483735e-3 |
GO:0050872 | white fat cell differentiation | 3.509574e-3 |
GO:0031573 | intra-S DNA damage checkpoint | 3.612448e-3 |
GO:0044342 | type B pancreatic cell proliferation | 3.621230e-3 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 3.621230e-3 |
GO:0042797 | tRNA transcription from RNA polymerase III promoter | 3.679342e-3 |
GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter | 3.679342e-3 |
GO:0006868 | glutamine transport | 3.679342e-3 |
GO:0090307 | spindle assembly involved in mitosis | 3.695048e-3 |
GO:0072668 | tubulin complex biogenesis | 3.721794e-3 |
GO:0048343 | paraxial mesodermal cell fate commitment | 3.739806e-3 |
GO:0072553 | terminal button organization | 3.772381e-3 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 3.772381e-3 |
GO:0000088 | mitotic prophase | 3.772381e-3 |
GO:0042761 | very long-chain fatty acid biosynthetic process | 3.799572e-3 |
GO:0035767 | endothelial cell chemotaxis | 3.829609e-3 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 3.946076e-3 |
GO:0010983 | positive regulation of high-density lipoprotein particle clearance | 3.946076e-3 |
GO:0022011 | myelination in peripheral nervous system | 4.045961e-3 |
GO:0046670 | positive regulation of retinal cell programmed cell death | 4.057883e-3 |
GO:2000340 | positive regulation of chemokine (C-X-C motif) ligand 1 production | 4.057883e-3 |
GO:0035665 | TIRAP-dependent toll-like receptor 4 signaling pathway | 4.057883e-3 |
GO:0043111 | replication fork arrest | 4.057883e-3 |
GO:0032738 | positive regulation of interleukin-15 production | 4.057883e-3 |
GO:0045415 | negative regulation of interleukin-8 biosynthetic process | 4.059970e-3 |
GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter | 4.243393e-3 |
GO:0072363 | regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter | 4.243393e-3 |
GO:0009133 | nucleoside diphosphate biosynthetic process | 4.315326e-3 |
GO:0051013 | microtubule severing | 4.375484e-3 |
GO:0019367 | fatty acid elongation, saturated fatty acid | 4.417666e-3 |
GO:0007051 | spindle organization | 4.466760e-3 |
GO:0032383 | regulation of intracellular cholesterol transport | 4.812912e-3 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 4.812912e-3 |
GO:0006287 | base-excision repair, gap-filling | 4.812912e-3 |
GO:0007288 | sperm axoneme assembly | 4.951830e-3 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 4.967611e-3 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 5.006864e-3 |
GO:0000089 | mitotic metaphase | 5.121902e-3 |
GO:0031929 | TOR signaling cascade | 5.241738e-3 |
GO:0003285 | septum secundum development | 5.383815e-3 |
GO:2000077 | negative regulation of type B pancreatic cell development | 5.434512e-3 |
GO:0035356 | cellular triglyceride homeostasis | 5.434512e-3 |
GO:0030421 | defecation | 5.434512e-3 |
GO:0072661 | protein targeting to plasma membrane | 5.456088e-3 |
GO:0042137 | sequestering of neurotransmitter | 5.456088e-3 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 5.477565e-3 |
GO:0043153 | entrainment of circadian clock by photoperiod | 5.560995e-3 |
GO:0006309 | DNA fragmentation involved in apoptotic nuclear change | 5.584405e-3 |
GO:0071072 | negative regulation of phospholipid biosynthetic process | 5.588941e-3 |
GO:0010822 | positive regulation of mitochondrion organization | 5.810200e-3 |
GO:0034048 | negative regulation of protein phosphatase type 2A activity | 6.018850e-3 |
GO:0042048 | olfactory behavior | 6.018850e-3 |
GO:0000387 | spliceosomal snRNP assembly | 6.060221e-3 |
GO:0043988 | histone H3-S28 phosphorylation | 6.181117e-3 |
GO:0043987 | histone H3-S10 phosphorylation | 6.181117e-3 |
GO:0090002 | establishment of protein localization in plasma membrane | 6.326482e-3 |
GO:0007090 | regulation of S phase of mitotic cell cycle | 6.431316e-3 |
GO:0006903 | vesicle targeting | 6.453625e-3 |
GO:0006853 | carnitine shuttle | 6.554975e-3 |
GO:0010591 | regulation of lamellipodium assembly | 6.575983e-3 |
GO:0051865 | protein autoubiquitination | 6.590511e-3 |
GO:0042420 | dopamine catabolic process | 6.687044e-3 |
GO:0007501 | mesodermal cell fate specification | 6.687044e-3 |
GO:0090030 | regulation of steroid hormone biosynthetic process | 6.690828e-3 |
GO:0070179 | D-serine biosynthetic process | 6.751641e-3 |
GO:0051793 | medium-chain fatty acid catabolic process | 6.751641e-3 |
GO:0071105 | response to interleukin-11 | 6.751641e-3 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 6.751641e-3 |
GO:0023035 | CD40 signaling pathway | 6.751641e-3 |
GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation | 6.751641e-3 |
GO:0048213 | Golgi vesicle prefusion complex stabilization | 6.751641e-3 |
GO:0042946 | glucoside transport | 6.751641e-3 |
GO:0035502 | metanephric ureteric bud development | 6.751641e-3 |
GO:0033260 | DNA replication involved in S phase | 6.751641e-3 |
GO:0035846 | oviduct epithelium development | 6.751641e-3 |
GO:0035847 | uterine epithelium development | 6.751641e-3 |
GO:0042747 | circadian sleep/wake cycle, REM sleep | 6.751641e-3 |
GO:0035852 | horizontal cell localization | 6.751641e-3 |
GO:0035849 | nephric duct elongation | 6.751641e-3 |
GO:0090150 | establishment of protein localization in membrane | 6.965618e-3 |
GO:0021893 | cerebral cortex GABAergic interneuron fate commitment | 6.996454e-3 |
GO:0003290 | atrial septum secundum morphogenesis | 6.996454e-3 |
GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment | 6.996454e-3 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 7.021456e-3 |
GO:0060923 | cardiac muscle cell fate commitment | 7.038709e-3 |
GO:0060716 | labyrinthine layer blood vessel development | 7.083138e-3 |
GO:0033057 | multicellular organismal reproductive behavior | 7.147225e-3 |
GO:0021707 | cerebellar granule cell differentiation | 7.171257e-3 |
GO:0000072 | M phase specific microtubule process | 7.188756e-3 |
GO:0006768 | biotin metabolic process | 7.235105e-3 |
GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter | 7.338958e-3 |
GO:0035094 | response to nicotine | 7.343241e-3 |
GO:0071071 | regulation of phospholipid biosynthetic process | 7.343707e-3 |
GO:0070574 | cadmium ion transmembrane transport | 7.343707e-3 |
GO:0090234 | regulation of kinetochore assembly | 7.562498e-3 |
GO:0090169 | regulation of spindle assembly | 7.562498e-3 |
GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 7.626758e-3 |
GO:0010225 | response to UV-C | 7.712393e-3 |
GO:0032218 | riboflavin transport | 7.819873e-3 |
GO:0035308 | negative regulation of protein dephosphorylation | 7.830878e-3 |
GO:2001054 | negative regulation of mesenchymal cell apoptosis | 7.910433e-3 |
GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly | 7.910433e-3 |
GO:0010107 | potassium ion import | 8.053584e-3 |
GO:0097151 | positive regulation of inhibitory postsynaptic membrane potential | 8.138461e-3 |
GO:0006474 | N-terminal protein amino acid acetylation | 8.169620e-3 |
GO:0019276 | UDP-N-acetylgalactosamine metabolic process | 8.183807e-3 |
GO:0060674 | placenta blood vessel development | 8.188770e-3 |
GO:0042942 | D-serine transport | 8.317387e-3 |
GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 8.317387e-3 |
GO:0097107 | postsynaptic density assembly | 8.317387e-3 |
GO:0031468 | nuclear envelope reassembly | 8.643017e-3 |
GO:0000354 | cis assembly of pre-catalytic spliceosome | 8.643017e-3 |
GO:0031119 | tRNA pseudouridine synthesis | 8.643017e-3 |
GO:0090192 | regulation of glomerulus development | 8.870297e-3 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 8.930608e-3 |
GO:0061032 | visceral serous pericardium development | 8.930608e-3 |
GO:0045918 | negative regulation of cytolysis | 9.088470e-3 |
GO:0007141 | male meiosis I | 9.143808e-3 |
GO:0045556 | positive regulation of TRAIL biosynthetic process | 9.219298e-3 |
GO:0032226 | positive regulation of synaptic transmission, dopaminergic | 9.219298e-3 |
GO:0000920 | cytokinetic cell separation | 9.364273e-3 |
GO:0033004 | negative regulation of mast cell activation | 9.498749e-3 |
GO:0001844 | protein insertion into mitochondrial membrane involved in induction of apoptosis | 9.532693e-3 |
GO:0030497 | fatty acid elongation | 9.560716e-3 |
GO:0045112 | integrin biosynthetic process | 9.770464e-3 |
GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 9.780140e-3 |
GO:0051220 | cytoplasmic sequestering of protein | 9.786507e-3 |
GO:0031124 | mRNA 3'-end processing | 9.829444e-3 |
GO:0043949 | regulation of cAMP-mediated signaling | 9.951611e-3 |
GO:0006189 | 'de novo' IMP biosynthetic process | 1.006266e-2 |
GO:0021603 | cranial nerve formation | 1.032373e-2 |
GO:0006337 | nucleosome disassembly | 1.058784e-2 |
GO:0006290 | pyrimidine dimer repair | 1.072045e-2 |
GO:0035357 | peroxisome proliferator activated receptor signaling pathway | 1.072045e-2 |
GO:0009440 | cyanate catabolic process | 1.074612e-2 |
GO:0042473 | outer ear morphogenesis | 1.084402e-2 |
GO:0019388 | galactose catabolic process | 1.088031e-2 |
GO:0043921 | modulation by host of viral transcription | 1.105441e-2 |
GO:0071157 | negative regulation of cell cycle arrest | 1.111372e-2 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 1.113740e-2 |
GO:0007339 | binding of sperm to zona pellucida | 1.113740e-2 |
GO:0071394 | cellular response to testosterone stimulus | 1.130855e-2 |
GO:0009253 | peptidoglycan catabolic process | 1.138187e-2 |
GO:0042117 | monocyte activation | 1.140360e-2 |
GO:0046398 | UDP-glucuronate metabolic process | 1.165479e-2 |
GO:0033085 | negative regulation of T cell differentiation in thymus | 1.172058e-2 |
GO:0048149 | behavioral response to ethanol | 1.209269e-2 |
GO:0042941 | D-alanine transport | 1.220813e-2 |
GO:0046674 | induction of retinal programmed cell death | 1.220813e-2 |
GO:0032976 | release of matrix enzymes from mitochondria | 1.220813e-2 |
GO:0048597 | post-embryonic camera-type eye morphogenesis | 1.220813e-2 |
GO:0002352 | B cell negative selection | 1.220813e-2 |
GO:0032802 | low-density lipoprotein particle receptor catabolic process | 1.220813e-2 |
GO:0008052 | sensory organ boundary specification | 1.220813e-2 |
GO:0001777 | T cell homeostatic proliferation | 1.220813e-2 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 1.220813e-2 |
GO:0043985 | histone H4-R3 methylation | 1.239560e-2 |
GO:0007023 | post-chaperonin tubulin folding pathway | 1.244667e-2 |
GO:0021837 | motogenic signaling involved in postnatal olfactory bulb interneuron migration | 1.266351e-2 |
GO:0002357 | defense response to tumor cell | 1.266351e-2 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 1.292025e-2 |
GO:0032793 | positive regulation of CREB transcription factor activity | 1.292962e-2 |
GO:0042423 | catecholamine biosynthetic process | 1.347351e-2 |
GO:0032312 | regulation of ARF GTPase activity | 1.353290e-2 |
GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 1.364554e-2 |
GO:0035814 | negative regulation of renal sodium excretion | 1.365035e-2 |
GO:0009225 | nucleotide-sugar metabolic process | 1.378088e-2 |
GO:0043487 | regulation of RNA stability | 1.390607e-2 |
GO:0050855 | regulation of B cell receptor signaling pathway | 1.398781e-2 |
GO:0033326 | cerebrospinal fluid secretion | 1.407389e-2 |
GO:0033133 | positive regulation of glucokinase activity | 1.407389e-2 |
GO:0016140 | O-glycoside metabolic process | 1.411087e-2 |
GO:0090222 | centrosome-templated microtubule nucleation | 1.411087e-2 |
GO:0072393 | microtubule anchoring at microtubule organizing center | 1.417075e-2 |
GO:0001661 | conditioned taste aversion | 1.428261e-2 |
GO:0060712 | spongiotrophoblast layer development | 1.444436e-2 |
GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 1.445222e-2 |
GO:0022027 | interkinetic nuclear migration | 1.445222e-2 |
GO:0030433 | ER-associated protein catabolic process | 1.468390e-2 |
GO:0046015 | regulation of transcription by glucose | 1.484904e-2 |
GO:0052312 | modulation of transcription in other organism involved in symbiotic interaction | 1.485552e-2 |
GO:0009132 | nucleoside diphosphate metabolic process | 1.485552e-2 |
GO:0046173 | polyol biosynthetic process | 1.499782e-2 |
GO:0006166 | purine ribonucleoside salvage | 1.499782e-2 |
GO:0006546 | glycine catabolic process | 1.510767e-2 |
GO:0018022 | peptidyl-lysine methylation | 1.532864e-2 |
GO:0021666 | rhombomere 5 formation | 1.561333e-2 |
GO:0021660 | rhombomere 3 formation | 1.561333e-2 |
GO:0006489 | dolichyl diphosphate biosynthetic process | 1.561333e-2 |
GO:0006450 | regulation of translational fidelity | 1.561333e-2 |
GO:0090230 | regulation of centromere complex assembly | 1.586880e-2 |
GO:0071034 | CUT catabolic process | 1.595302e-2 |
GO:0010835 | regulation of protein ADP-ribosylation | 1.595302e-2 |
GO:0003180 | aortic valve morphogenesis | 1.602388e-2 |
GO:0009219 | pyrimidine deoxyribonucleotide metabolic process | 1.602388e-2 |
GO:0007386 | compartment pattern specification | 1.605772e-2 |
GO:0009648 | photoperiodism | 1.613750e-2 |
GO:0072361 | regulation of glycolysis by regulation of transcription from RNA polymerase II promoter | 1.614034e-2 |
GO:0032205 | negative regulation of telomere maintenance | 1.614471e-2 |
GO:0048320 | axial mesoderm formation | 1.631257e-2 |
GO:0042218 | 1-aminocyclopropane-1-carboxylate biosynthetic process | 1.631257e-2 |
GO:0040015 | negative regulation of multicellular organism growth | 1.658051e-2 |
GO:0015886 | heme transport | 1.661215e-2 |
GO:0010624 | regulation of Schwann cell proliferation | 1.672702e-2 |
GO:0051764 | actin crosslink formation | 1.675776e-2 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 1.701394e-2 |
GO:0072060 | outer medullary collecting duct development | 1.723638e-2 |
GO:0072061 | inner medullary collecting duct development | 1.723638e-2 |
GO:0034047 | regulation of protein phosphatase type 2A activity | 1.723638e-2 |
GO:0016332 | establishment or maintenance of polarity of embryonic epithelium | 1.723638e-2 |
GO:0009637 | response to blue light | 1.723638e-2 |
GO:0000380 | alternative nuclear mRNA splicing, via spliceosome | 1.729211e-2 |
GO:2000009 | negative regulation of protein localization at cell surface | 1.760333e-2 |
GO:0071469 | cellular response to alkalinity | 1.760333e-2 |
GO:0016073 | snRNA metabolic process | 1.791421e-2 |
GO:0045719 | negative regulation of glycogen biosynthetic process | 1.815424e-2 |
GO:0006168 | adenine salvage | 1.818516e-2 |
GO:0060061 | Spemann organizer formation | 1.827792e-2 |
GO:0006206 | pyrimidine base metabolic process | 1.836202e-2 |
GO:0035811 | negative regulation of urine volume | 1.842175e-2 |
GO:0034971 | histone H3-R17 methylation | 1.842599e-2 |
GO:0010477 | response to sulfur dioxide | 1.842599e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0016567 | protein ubiquitination | 7.160585e-8 |
GO:0032446 | protein modification by small protein conjugation | 1.290886e-7 |
GO:0007144 | female meiosis I | 2.175648e-7 |
GO:0090083 | regulation of inclusion body assembly | 3.938402e-7 |
GO:0015780 | nucleotide-sugar transport | 7.341632e-7 |
GO:0016926 | protein desumoylation | 1.440876e-6 |
GO:0031577 | spindle checkpoint | 1.708912e-6 |
GO:0032312 | regulation of ARF GTPase activity | 1.711558e-6 |
GO:0090169 | regulation of spindle assembly | 1.765722e-6 |
GO:0090234 | regulation of kinetochore assembly | 1.765722e-6 |
GO:0006398 | histone mRNA 3'-end processing | 2.211431e-6 |
GO:0070286 | axonemal dynein complex assembly | 2.617723e-6 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 3.303853e-6 |
GO:0071422 | succinate transmembrane transport | 3.674075e-6 |
GO:0045647 | negative regulation of erythrocyte differentiation | 3.870560e-6 |
GO:0018023 | peptidyl-lysine trimethylation | 4.325327e-6 |
GO:0071173 | spindle assembly checkpoint | 7.163733e-6 |
GO:0043457 | regulation of cellular respiration | 7.772145e-6 |
GO:0045542 | positive regulation of cholesterol biosynthetic process | 8.569599e-6 |
GO:0090224 | regulation of spindle organization | 1.262632e-5 |
GO:0035674 | tricarboxylic acid transmembrane transport | 1.471046e-5 |
GO:0090084 | negative regulation of inclusion body assembly | 1.519908e-5 |
GO:0008608 | attachment of spindle microtubules to kinetochore | 1.659424e-5 |
GO:0008334 | histone mRNA metabolic process | 2.020666e-5 |
GO:0010467 | gene expression | 2.245096e-5 |
GO:0033169 | histone H3-K9 demethylation | 2.444059e-5 |
GO:0046984 | regulation of hemoglobin biosynthetic process | 2.899102e-5 |
GO:0046882 | negative regulation of follicle-stimulating hormone secretion | 3.186622e-5 |
GO:0006184 | GTP catabolic process | 3.746728e-5 |
GO:0046599 | regulation of centriole replication | 5.538465e-5 |
GO:0051586 | positive regulation of dopamine uptake | 5.970891e-5 |
GO:0051865 | protein autoubiquitination | 6.134340e-5 |
GO:0006346 | methylation-dependent chromatin silencing | 6.751535e-5 |
GO:0070831 | basement membrane assembly | 7.024566e-5 |
GO:0006403 | RNA localization | 1.019036e-4 |
GO:0046605 | regulation of centrosome cycle | 1.024124e-4 |
GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 1.200389e-4 |
GO:0031508 | centromeric heterochromatin formation | 1.219503e-4 |
GO:0033239 | negative regulation of cellular amine metabolic process | 1.264477e-4 |
GO:0070647 | protein modification by small protein conjugation or removal | 1.341048e-4 |
GO:0018293 | protein-FAD linkage | 1.361953e-4 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 1.361953e-4 |
GO:0046039 | GTP metabolic process | 1.379786e-4 |
GO:0043558 | regulation of translational initiation in response to stress | 1.609184e-4 |
GO:0090231 | regulation of spindle checkpoint | 1.730227e-4 |
GO:0006474 | N-terminal protein amino acid acetylation | 1.796549e-4 |
GO:0051168 | nuclear export | 1.843826e-4 |
GO:0010870 | positive regulation of receptor biosynthetic process | 1.865163e-4 |
GO:0051313 | attachment of spindle microtubules to chromosome | 1.957733e-4 |
GO:0016070 | RNA metabolic process | 2.149013e-4 |
GO:0060375 | regulation of mast cell differentiation | 2.241646e-4 |
GO:0034446 | substrate adhesion-dependent cell spreading | 2.319167e-4 |
GO:0001672 | regulation of chromatin assembly or disassembly | 2.440799e-4 |
GO:0070845 | polyubiquitinated misfolded protein transport | 2.452481e-4 |
GO:0060160 | negative regulation of dopamine receptor signaling pathway | 2.452481e-4 |
GO:0009817 | defense response to fungus, incompatible interaction | 2.452481e-4 |
GO:0034436 | glycoprotein transport | 2.452481e-4 |
GO:0015891 | siderophore transport | 2.914452e-4 |
GO:0008298 | intracellular mRNA localization | 2.914452e-4 |
GO:0032863 | activation of Rac GTPase activity | 3.183169e-4 |
GO:2000383 | regulation of ectoderm development | 3.202693e-4 |
GO:0090086 | negative regulation of protein deubiquitination | 3.224785e-4 |
GO:0006342 | chromatin silencing | 3.246394e-4 |
GO:0035441 | cell migration involved in vasculogenesis | 3.342055e-4 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 3.342055e-4 |
GO:0051004 | regulation of lipoprotein lipase activity | 3.367255e-4 |
GO:0010452 | histone H3-K36 methylation | 3.374310e-4 |
GO:0003221 | right ventricular cardiac muscle tissue morphogenesis | 3.460956e-4 |
GO:0006438 | valyl-tRNA aminoacylation | 3.460956e-4 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 3.594392e-4 |
GO:0006611 | protein export from nucleus | 3.780298e-4 |
GO:0034587 | piRNA metabolic process | 3.808429e-4 |
GO:0061034 | olfactory bulb mitral cell layer development | 3.861195e-4 |
GO:0007168 | receptor guanylyl cyclase signaling pathway | 3.861195e-4 |
GO:0007051 | spindle organization | 3.980366e-4 |
GO:0006409 | tRNA export from nucleus | 4.143989e-4 |
GO:0019047 | provirus integration | 4.143989e-4 |
GO:0045793 | positive regulation of cell size | 4.427410e-4 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 4.781387e-4 |
GO:0045799 | positive regulation of chromatin assembly or disassembly | 4.781387e-4 |
GO:0060217 | hemangioblast cell differentiation | 4.781387e-4 |
GO:0006325 | chromatin organization | 5.530364e-4 |
GO:0035855 | megakaryocyte development | 5.585823e-4 |
GO:0018364 | peptidyl-glutamine methylation | 6.027461e-4 |
GO:0007183 | SMAD protein complex assembly | 6.224141e-4 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 6.327482e-4 |
GO:0071157 | negative regulation of cell cycle arrest | 6.479802e-4 |
GO:0046102 | inosine metabolic process | 6.858363e-4 |
GO:2000384 | negative regulation of ectoderm development | 6.882277e-4 |
GO:0035520 | monoubiquitinated protein deubiquitination | 7.321319e-4 |
GO:0072661 | protein targeting to plasma membrane | 7.488018e-4 |
GO:0042304 | regulation of fatty acid biosynthetic process | 7.590225e-4 |
GO:0006261 | DNA-dependent DNA replication | 7.879710e-4 |
GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 8.482778e-4 |
GO:0032774 | RNA biosynthetic process | 8.495444e-4 |
GO:0050658 | RNA transport | 8.602848e-4 |
GO:0070625 | zymogen granule exocytosis | 8.676711e-4 |
GO:0050685 | positive regulation of mRNA processing | 8.696323e-4 |
GO:0010888 | negative regulation of lipid storage | 8.696323e-4 |
GO:0032465 | regulation of cytokinesis | 8.835044e-4 |
GO:0014812 | muscle cell migration | 8.928459e-4 |
GO:0010799 | regulation of peptidyl-threonine phosphorylation | 9.163041e-4 |
GO:0006351 | transcription, DNA-dependent | 9.178063e-4 |
GO:0018205 | peptidyl-lysine modification | 9.696061e-4 |
GO:0030902 | hindbrain development | 9.796364e-4 |
GO:0090304 | nucleic acid metabolic process | 1.020363e-3 |
GO:0016226 | iron-sulfur cluster assembly | 1.064982e-3 |
GO:0038007 | netrin-activated signaling pathway | 1.081543e-3 |
GO:0032277 | negative regulation of gonadotropin secretion | 1.081543e-3 |
GO:0051567 | histone H3-K9 methylation | 1.152146e-3 |
GO:0045116 | protein neddylation | 1.164692e-3 |
GO:0000183 | chromatin silencing at rDNA | 1.184233e-3 |
GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain | 1.185151e-3 |
GO:0071777 | positive regulation of cell cycle cytokinesis | 1.220716e-3 |
GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination | 1.223059e-3 |
GO:2000682 | positive regulation of rubidium ion transport | 1.260862e-3 |
GO:2000688 | positive regulation of rubidium ion transmembrane transporter activity | 1.260862e-3 |
GO:0035826 | rubidium ion transport | 1.260862e-3 |
GO:0021528 | commissural neuron differentiation in spinal cord | 1.260862e-3 |
GO:0043128 | positive regulation of 1-phosphatidylinositol 4-kinase activity | 1.260862e-3 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 1.457425e-3 |
GO:0032057 | negative regulation of translational initiation in response to stress | 1.457425e-3 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 1.487313e-3 |
GO:0030219 | megakaryocyte differentiation | 1.517582e-3 |
GO:0042048 | olfactory behavior | 1.566570e-3 |
GO:0050668 | positive regulation of homocysteine metabolic process | 1.585866e-3 |
GO:0015746 | citrate transport | 1.585866e-3 |
GO:0045963 | negative regulation of dopamine metabolic process | 1.585866e-3 |
GO:0045922 | negative regulation of fatty acid metabolic process | 1.616651e-3 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 1.632375e-3 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 1.632375e-3 |
GO:0043973 | histone H3-K4 acetylation | 1.632375e-3 |
GO:0017183 | peptidyl-diphthamide biosynthetic process from peptidyl-histidine | 1.650658e-3 |
GO:0002098 | tRNA wobble uridine modification | 1.650658e-3 |
GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 1.650658e-3 |
GO:0033108 | mitochondrial respiratory chain complex assembly | 1.755733e-3 |
GO:0031365 | N-terminal protein amino acid modification | 1.775465e-3 |
GO:0055099 | response to high density lipoprotein particle stimulus | 1.845294e-3 |
GO:0032467 | positive regulation of cytokinesis | 1.892768e-3 |
GO:0032981 | mitochondrial respiratory chain complex I assembly | 1.978203e-3 |
GO:0006359 | regulation of transcription from RNA polymerase III promoter | 1.978203e-3 |
GO:0046498 | S-adenosylhomocysteine metabolic process | 2.014482e-3 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 2.056141e-3 |
GO:0060285 | ciliary cell motility | 2.056141e-3 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 2.103104e-3 |
GO:0051297 | centrosome organization | 2.141506e-3 |
GO:0045931 | positive regulation of mitotic cell cycle | 2.259423e-3 |
GO:0010891 | negative regulation of sequestering of triglyceride | 2.268934e-3 |
GO:0060708 | spongiotrophoblast differentiation | 2.281842e-3 |
GO:0050779 | RNA destabilization | 2.356997e-3 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 2.361824e-3 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 2.361824e-3 |
GO:0035470 | positive regulation of vascular wound healing | 2.361824e-3 |
GO:0031119 | tRNA pseudouridine synthesis | 2.361824e-3 |
GO:0090150 | establishment of protein localization in membrane | 2.762372e-3 |
GO:2000381 | negative regulation of mesoderm development | 2.764271e-3 |
GO:0033505 | floor plate morphogenesis | 2.764271e-3 |
GO:0021893 | cerebral cortex GABAergic interneuron fate commitment | 2.764271e-3 |
GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment | 2.764271e-3 |
GO:0031507 | heterochromatin formation | 2.931435e-3 |
GO:0042660 | positive regulation of cell fate specification | 3.007747e-3 |
GO:0009648 | photoperiodism | 3.007747e-3 |
GO:0000413 | protein peptidyl-prolyl isomerization | 3.076601e-3 |
GO:2000001 | regulation of DNA damage checkpoint | 3.077499e-3 |
GO:0042492 | gamma-delta T cell differentiation | 3.077499e-3 |
GO:0051775 | response to redox state | 3.077499e-3 |
GO:0048285 | organelle fission | 3.142768e-3 |
GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development | 3.197194e-3 |
GO:0000212 | meiotic spindle organization | 3.197194e-3 |
GO:0018243 | protein O-linked glycosylation via threonine | 3.237124e-3 |
GO:0018242 | protein O-linked glycosylation via serine | 3.237124e-3 |
GO:0007067 | mitosis | 3.282710e-3 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 3.344718e-3 |
GO:0007052 | mitotic spindle organization | 3.344718e-3 |
GO:0000279 | M phase | 3.350123e-3 |
GO:0042823 | pyridoxal phosphate biosynthetic process | 3.432861e-3 |
GO:0010887 | negative regulation of cholesterol storage | 3.457529e-3 |
GO:0015781 | pyrimidine nucleotide-sugar transport | 3.457822e-3 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 3.457822e-3 |
GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent | 3.457822e-3 |
GO:0060179 | male mating behavior | 3.565930e-3 |
GO:0019509 | L-methionine salvage from methylthioadenosine | 3.565930e-3 |
GO:0046755 | non-lytic virus budding | 3.594121e-3 |
GO:0046103 | inosine biosynthetic process | 3.594121e-3 |
GO:0006154 | adenosine catabolic process | 3.594121e-3 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 3.594121e-3 |
GO:0000087 | M phase of mitotic cell cycle | 3.717312e-3 |
GO:0006493 | protein O-linked glycosylation | 3.803525e-3 |
GO:0034227 | tRNA thio-modification | 3.835488e-3 |
GO:0018027 | peptidyl-lysine dimethylation | 3.835773e-3 |
GO:0034339 | regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 3.835773e-3 |
GO:0051882 | mitochondrial depolarization | 3.836265e-3 |
GO:0048291 | isotype switching to IgG isotypes | 3.836265e-3 |
GO:0002368 | B cell cytokine production | 3.836265e-3 |
GO:0030150 | protein import into mitochondrial matrix | 3.836265e-3 |
GO:0033617 | mitochondrial respiratory chain complex IV assembly | 3.836265e-3 |
GO:0060319 | primitive erythrocyte differentiation | 3.972558e-3 |
GO:0060712 | spongiotrophoblast layer development | 3.996157e-3 |
GO:0016568 | chromatin modification | 4.088435e-3 |
GO:0007216 | metabotropic glutamate receptor signaling pathway | 4.163786e-3 |
GO:0035104 | positive regulation of transcription via sterol regulatory element binding | 4.164611e-3 |
GO:0032288 | myelin assembly | 4.204144e-3 |
GO:0072095 | regulation of branch elongation involved in ureteric bud branching | 4.228682e-3 |
GO:0051351 | positive regulation of ligase activity | 4.274927e-3 |
GO:0051451 | myoblast migration | 4.307917e-3 |
GO:0035307 | positive regulation of protein dephosphorylation | 4.377063e-3 |
GO:0003062 | regulation of heart rate by chemical signal | 4.409575e-3 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 4.587041e-3 |
GO:0090002 | establishment of protein localization in plasma membrane | 4.777231e-3 |
GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 4.777231e-3 |
GO:0009048 | dosage compensation, by inactivation of X chromosome | 4.777231e-3 |
GO:0045040 | protein import into mitochondrial outer membrane | 4.777231e-3 |
GO:0045814 | negative regulation of gene expression, epigenetic | 4.909798e-3 |
GO:0032933 | SREBP-mediated signaling pathway | 5.086668e-3 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 5.086668e-3 |
GO:0010824 | regulation of centrosome duplication | 5.181120e-3 |
GO:0010735 | positive regulation of transcription via serum response element binding | 5.372866e-3 |
GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c | 5.372866e-3 |
GO:0000729 | DNA double-strand break processing | 5.372866e-3 |
GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter | 5.411668e-3 |
GO:0048714 | positive regulation of oligodendrocyte differentiation | 5.422756e-3 |
GO:0035306 | positive regulation of dephosphorylation | 5.422756e-3 |
GO:0051028 | mRNA transport | 5.535914e-3 |
GO:0051276 | chromosome organization | 5.933074e-3 |
GO:0046881 | positive regulation of follicle-stimulating hormone secretion | 5.951773e-3 |
GO:0043153 | entrainment of circadian clock by photoperiod | 5.951773e-3 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 5.980968e-3 |
GO:0072513 | positive regulation of secondary heart field cardioblast proliferation | 6.040182e-3 |
GO:0043555 | regulation of translation in response to stress | 6.040182e-3 |
GO:0032922 | circadian regulation of gene expression | 6.050136e-3 |
GO:0014047 | glutamate secretion | 6.050136e-3 |
GO:0090307 | spindle assembly involved in mitosis | 6.289420e-3 |
GO:0055107 | Golgi to secretory granule transport | 6.339638e-3 |
GO:0046986 | negative regulation of hemoglobin biosynthetic process | 6.339638e-3 |
GO:2000781 | positive regulation of double-strand break repair | 6.339638e-3 |
GO:0006021 | inositol biosynthetic process | 6.339638e-3 |
GO:0019064 | viral envelope fusion with host membrane | 6.339638e-3 |
GO:0021586 | pons maturation | 6.339638e-3 |
GO:0046814 | virion attachment, binding of host cell surface coreceptor | 6.339638e-3 |
GO:0008617 | guanosine metabolic process | 6.541112e-3 |
GO:0033120 | positive regulation of RNA splicing | 6.644152e-3 |
GO:0007099 | centriole replication | 6.717702e-3 |
GO:0046015 | regulation of transcription by glucose | 6.880184e-3 |
GO:0033083 | regulation of immature T cell proliferation | 6.891547e-3 |
GO:0032007 | negative regulation of TOR signaling cascade | 6.952245e-3 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 7.009351e-3 |
GO:0060286 | flagellar cell motility | 7.110782e-3 |
GO:0035562 | negative regulation of chromatin binding | 7.110782e-3 |
GO:0046499 | S-adenosylmethioninamine metabolic process | 7.218141e-3 |
GO:0002031 | G-protein coupled receptor internalization | 7.424793e-3 |
GO:0072500 | negative regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 7.591359e-3 |
GO:0051315 | attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation | 7.591359e-3 |
GO:0000059 | protein import into nucleus, docking | 7.591359e-3 |
GO:0015790 | UDP-xylose transport | 7.591359e-3 |
GO:0015788 | UDP-N-acetylglucosamine transport | 7.591359e-3 |
GO:0045585 | positive regulation of cytotoxic T cell differentiation | 7.610631e-3 |
GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing | 7.610631e-3 |
GO:0048368 | lateral mesoderm development | 7.737589e-3 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 7.768055e-3 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 7.900524e-3 |
GO:0072199 | regulation of mesenchymal cell proliferation involved in ureter development | 7.918362e-3 |
GO:0072553 | terminal button organization | 7.958715e-3 |
GO:0008616 | queuosine biosynthetic process | 7.958715e-3 |
GO:0031129 | inductive cell-cell signaling | 7.958715e-3 |
GO:0072061 | inner medullary collecting duct development | 7.961211e-3 |
GO:0072060 | outer medullary collecting duct development | 7.961211e-3 |
GO:0016332 | establishment or maintenance of polarity of embryonic epithelium | 7.961211e-3 |
GO:0045924 | regulation of female receptivity | 7.980160e-3 |
GO:0042775 | mitochondrial ATP synthesis coupled electron transport | 7.980160e-3 |
GO:0016601 | Rac protein signal transduction | 7.998342e-3 |
GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase | 8.022673e-3 |
GO:0033566 | gamma-tubulin complex localization | 8.022673e-3 |
GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I | 8.022673e-3 |
GO:0051225 | spindle assembly | 8.142040e-3 |
GO:0022038 | corpus callosum development | 8.168237e-3 |
GO:0034619 | cellular chaperone-mediated protein complex assembly | 8.284882e-3 |
GO:0016458 | gene silencing | 8.519665e-3 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 8.558608e-3 |
GO:0018022 | peptidyl-lysine methylation | 8.561829e-3 |
GO:0006352 | transcription initiation, DNA-dependent | 8.997695e-3 |
GO:0071267 | L-methionine salvage | 9.024900e-3 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 9.027464e-3 |
GO:0072172 | mesonephric tubule formation | 9.164690e-3 |
GO:0060696 | regulation of phospholipid catabolic process | 9.164690e-3 |
GO:0090218 | positive regulation of lipid kinase activity | 9.512209e-3 |
GO:0006396 | RNA processing | 9.842638e-3 |
GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide | 1.020425e-2 |
GO:0001522 | pseudouridine synthesis | 1.021445e-2 |
GO:0000910 | cytokinesis | 1.055173e-2 |
GO:0007049 | cell cycle | 1.061743e-2 |
GO:0030033 | microvillus assembly | 1.063183e-2 |
GO:0000432 | positive regulation of transcription from RNA polymerase II promoter by glucose | 1.063183e-2 |
GO:0034382 | chylomicron remnant clearance | 1.065626e-2 |
GO:0030259 | lipid glycosylation | 1.065626e-2 |
GO:0090085 | regulation of protein deubiquitination | 1.091564e-2 |
GO:0033088 | negative regulation of immature T cell proliferation in thymus | 1.091564e-2 |
GO:0018076 | N-terminal peptidyl-lysine acetylation | 1.091564e-2 |
GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 1.091564e-2 |
GO:2000142 | regulation of transcription initiation, DNA-dependent | 1.091978e-2 |
GO:0060215 | primitive hemopoiesis | 1.097722e-2 |
GO:0000725 | recombinational repair | 1.108484e-2 |
GO:0050684 | regulation of mRNA processing | 1.116969e-2 |
GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 1.119443e-2 |
GO:2000649 | regulation of sodium ion transmembrane transporter activity | 1.139445e-2 |
GO:0045654 | positive regulation of megakaryocyte differentiation | 1.139445e-2 |
GO:0021508 | floor plate formation | 1.149709e-2 |
GO:0035502 | metanephric ureteric bud development | 1.167192e-2 |
GO:0080164 | regulation of nitric oxide metabolic process | 1.167192e-2 |
GO:0017187 | peptidyl-glutamic acid carboxylation | 1.167192e-2 |
GO:0033326 | cerebrospinal fluid secretion | 1.167192e-2 |
GO:0007057 | spindle assembly involved in female meiosis I | 1.167192e-2 |
GO:0016482 | cytoplasmic transport | 1.167192e-2 |
GO:0009443 | pyridoxal 5'-phosphate salvage | 1.167192e-2 |
GO:0006683 | galactosylceramide catabolic process | 1.167192e-2 |
GO:0035329 | hippo signaling cascade | 1.200803e-2 |
GO:0016575 | histone deacetylation | 1.231218e-2 |
GO:0045875 | negative regulation of sister chromatid cohesion | 1.289037e-2 |
GO:0018206 | peptidyl-methionine modification | 1.289037e-2 |
GO:0060180 | female mating behavior | 1.298593e-2 |
GO:0031440 | regulation of mRNA 3'-end processing | 1.323583e-2 |
GO:0022037 | metencephalon development | 1.342197e-2 |
GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter | 1.343865e-2 |
GO:0018202 | peptidyl-histidine modification | 1.379799e-2 |
GO:0061056 | sclerotome development | 1.396844e-2 |
GO:0018193 | peptidyl-amino acid modification | 1.409293e-2 |
GO:0021568 | rhombomere 2 development | 1.415435e-2 |
GO:0048733 | sebaceous gland development | 1.415435e-2 |
GO:0006383 | transcription from RNA polymerase III promoter | 1.415435e-2 |
GO:0006269 | DNA replication, synthesis of RNA primer | 1.415435e-2 |
GO:0018394 | peptidyl-lysine acetylation | 1.416065e-2 |
GO:0060347 | heart trabecula formation | 1.426740e-2 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 1.435180e-2 |
GO:0032226 | positive regulation of synaptic transmission, dopaminergic | 1.435180e-2 |
GO:0002082 | regulation of oxidative phosphorylation | 1.435180e-2 |
GO:0051340 | regulation of ligase activity | 1.436300e-2 |
GO:0035645 | enteric smooth muscle cell differentiation | 1.437430e-2 |
GO:0061088 | regulation of sequestering of zinc ion | 1.437430e-2 |
GO:0000395 | nuclear mRNA 5'-splice site recognition | 1.437430e-2 |
GO:0030719 | P granule organization | 1.437430e-2 |
GO:0022616 | DNA strand elongation | 1.437430e-2 |
GO:0007497 | posterior midgut development | 1.437430e-2 |
GO:0045723 | positive regulation of fatty acid biosynthetic process | 1.438688e-2 |
GO:0051645 | Golgi localization | 1.485477e-2 |
GO:0032365 | intracellular lipid transport | 1.485477e-2 |
GO:0070534 | protein K63-linked ubiquitination | 1.504086e-2 |
GO:0010822 | positive regulation of mitochondrion organization | 1.518857e-2 |
GO:0010457 | centriole-centriole cohesion | 1.521549e-2 |
GO:0006391 | transcription initiation from mitochondrial promoter | 1.581498e-2 |
GO:0032513 | negative regulation of protein phosphatase type 2B activity | 1.581498e-2 |
GO:0060482 | lobar bronchus development | 1.583703e-2 |
GO:0060017 | parathyroid gland development | 1.600392e-2 |
GO:0051590 | positive regulation of neurotransmitter transport | 1.600392e-2 |
GO:0006290 | pyrimidine dimer repair | 1.612353e-2 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.613450e-2 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 1.634801e-2 |
GO:0051292 | nuclear pore complex assembly | 1.648506e-2 |
GO:0000414 | regulation of histone H3-K36 methylation | 1.648506e-2 |
GO:0046604 | positive regulation of mitotic centrosome separation | 1.671328e-2 |
GO:0048227 | plasma membrane to endosome transport | 1.671328e-2 |
GO:0032532 | regulation of microvillus length | 1.671328e-2 |
GO:0065002 | intracellular protein transmembrane transport | 1.671328e-2 |
GO:0002502 | peptide antigen assembly with MHC class I protein complex | 1.671328e-2 |
GO:0001682 | tRNA 5'-leader removal | 1.671328e-2 |
GO:0016078 | tRNA catabolic process | 1.671328e-2 |
GO:0032065 | cortical protein anchoring | 1.671328e-2 |
GO:0008156 | negative regulation of DNA replication | 1.687265e-2 |
GO:0010896 | regulation of triglyceride catabolic process | 1.703618e-2 |
GO:0006713 | glucocorticoid catabolic process | 1.715238e-2 |
GO:0006408 | snRNA export from nucleus | 1.715238e-2 |
GO:0034260 | negative regulation of GTPase activity | 1.755911e-2 |
GO:0006405 | RNA export from nucleus | 1.755957e-2 |
GO:0032717 | negative regulation of interleukin-8 production | 1.760541e-2 |
GO:0031023 | microtubule organizing center organization | 1.779869e-2 |
GO:0060446 | branching involved in open tracheal system development | 1.812370e-2 |
GO:0060461 | right lung morphogenesis | 1.812370e-2 |
GO:0097152 | mesenchymal cell apoptosis | 1.812370e-2 |
GO:0090131 | mesenchyme migration | 1.812370e-2 |
GO:0048613 | embryonic ectodermal digestive tract morphogenesis | 1.812370e-2 |
GO:0048371 | lateral mesodermal cell differentiation | 1.812370e-2 |
GO:0008355 | olfactory learning | 1.812370e-2 |
GO:0014822 | detection of wounding | 1.812370e-2 |
GO:0060928 | atrioventricular node cell development | 1.827308e-2 |
GO:0034162 | toll-like receptor 9 signaling pathway | 1.827308e-2 |
GO:0033314 | mitotic cell cycle DNA replication checkpoint | 1.827308e-2 |
GO:0060929 | atrioventricular node cell fate commitment | 1.827308e-2 |
GO:0034138 | toll-like receptor 3 signaling pathway | 1.827308e-2 |
GO:0090042 | tubulin deacetylation | 1.827308e-2 |
GO:0032782 | bile acid secretion | 1.827308e-2 |
GO:0097151 | positive regulation of inhibitory postsynaptic membrane potential | 1.827308e-2 |
GO:0090324 | negative regulation of oxidative phosphorylation | 1.827308e-2 |
GO:0070086 | ubiquitin-dependent endocytosis | 1.827308e-2 |
GO:0070846 | Hsp90 deacetylation | 1.827308e-2 |
GO:0000963 | mitochondrial RNA processing | 1.827308e-2 |
GO:0031120 | snRNA pseudouridine synthesis | 1.827308e-2 |
GO:0001966 | thigmotaxis | 1.827308e-2 |
GO:0001579 | medium-chain fatty acid transport | 1.827308e-2 |
GO:0003168 | cardiac Purkinje fiber cell differentiation | 1.827308e-2 |
GO:0003096 | renal sodium ion transport | 1.827308e-2 |
GO:0010725 | regulation of primitive erythrocyte differentiation | 1.827308e-2 |
GO:0010255 | glucose mediated signaling pathway | 1.827308e-2 |
GO:0007630 | jump response | 1.827308e-2 |
GO:0003342 | proepicardium development | 1.827308e-2 |
GO:0010216 | maintenance of DNA methylation | 1.841733e-2 |
GO:0060124 | positive regulation of growth hormone secretion | 1.862474e-2 |
GO:0051016 | barbed-end actin filament capping | 1.863092e-2 |
GO:0045292 | nuclear mRNA cis splicing, via spliceosome | 1.863092e-2 |
GO:0048382 | mesendoderm development | 1.889085e-2 |
GO:0021930 | cerebellar granule cell precursor proliferation | 1.889085e-2 |
GO:0048859 | formation of anatomical boundary | 1.889530e-2 |
GO:0006289 | nucleotide-excision repair | 1.898703e-2 |
GO:0018393 | internal peptidyl-lysine acetylation | 1.910708e-2 |
GO:0022403 | cell cycle phase | 1.924943e-2 |
GO:0051298 | centrosome duplication | 1.925517e-2 |
GO:0046580 | negative regulation of Ras protein signal transduction | 1.944044e-2 |
GO:0034442 | regulation of lipoprotein oxidation | 1.944679e-2 |
GO:0016577 | histone demethylation | 2.013104e-2 |
GO:0021549 | cerebellum development | 2.014393e-2 |
GO:0030163 | protein catabolic process | 2.034957e-2 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 2.035770e-2 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 2.038298e-2 |
GO:0017004 | cytochrome complex assembly | 2.039066e-2 |
GO:0060535 | trachea cartilage morphogenesis | 2.073191e-2 |
GO:0007619 | courtship behavior | 2.073191e-2 |
GO:0016569 | covalent chromatin modification | 2.092535e-2 |
GO:0050965 | detection of temperature stimulus involved in sensory perception of pain | 2.120811e-2 |
GO:0007621 | negative regulation of female receptivity | 2.153106e-2 |
GO:0061188 | negative regulation of chromatin silencing at rDNA | 2.185625e-2 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 2.196939e-2 |
GO:0010869 | regulation of receptor biosynthetic process | 2.203994e-2 |
GO:0070979 | protein K11-linked ubiquitination | 2.250977e-2 |
GO:0007212 | dopamine receptor signaling pathway | 2.259775e-2 |
GO:0032367 | intracellular cholesterol transport | 2.308809e-2 |
GO:0033523 | histone H2B ubiquitination | 2.331114e-2 |
GO:0006473 | protein acetylation | 2.346597e-2 |
GO:0010498 | proteasomal protein catabolic process | 2.361377e-2 |
GO:0006139 | nucleobase-containing compound metabolic process | 2.371725e-2 |
GO:0032508 | DNA duplex unwinding | 2.399155e-2 |
GO:0021904 | dorsal/ventral neural tube patterning | 2.432784e-2 |
GO:0060158 | activation of phospholipase C activity by dopamine receptor signaling pathway | 2.457898e-2 |
GO:0051301 | cell division | 2.461802e-2 |
GO:0046836 | glycolipid transport | 2.469610e-2 |
GO:0045713 | low-density lipoprotein particle receptor biosynthetic process | 2.469610e-2 |
GO:0035269 | protein O-linked mannosylation | 2.469610e-2 |
GO:0006601 | creatine biosynthetic process | 2.469610e-2 |
GO:0006415 | translational termination | 2.481961e-2 |
GO:0021696 | cerebellar cortex morphogenesis | 2.500419e-2 |
GO:0042773 | ATP synthesis coupled electron transport | 2.527419e-2 |
GO:0070842 | aggresome assembly | 2.530161e-2 |
GO:0019941 | modification-dependent protein catabolic process | 2.535112e-2 |
GO:0048713 | regulation of oligodendrocyte differentiation | 2.539447e-2 |
GO:0043632 | modification-dependent macromolecule catabolic process | 2.541645e-2 |
GO:0006268 | DNA unwinding involved in replication | 2.547418e-2 |
GO:0046847 | filopodium assembly | 2.559524e-2 |
GO:0051320 | S phase | 2.578584e-2 |
GO:0046500 | S-adenosylmethionine metabolic process | 2.578584e-2 |
GO:0006013 | mannose metabolic process | 2.602639e-2 |
GO:0048935 | peripheral nervous system neuron development | 2.684768e-2 |
GO:0032784 | regulation of transcription elongation, DNA-dependent | 2.719241e-2 |
GO:0021527 | spinal cord association neuron differentiation | 2.766652e-2 |
GO:0051321 | meiotic cell cycle | 2.785195e-2 |
GO:0060159 | regulation of dopamine receptor signaling pathway | 2.788011e-2 |
GO:0046952 | ketone body catabolic process | 2.812152e-2 |
GO:0033572 | transferrin transport | 2.812152e-2 |
GO:0045010 | actin nucleation | 2.815569e-2 |
GO:0034501 | protein localization to kinetochore | 2.815569e-2 |
GO:0016048 | detection of temperature stimulus | 2.815569e-2 |
GO:0046485 | ether lipid metabolic process | 2.851794e-2 |
GO:0045906 | negative regulation of vasoconstriction | 2.867795e-2 |
GO:2000772 | regulation of cellular senescence | 2.875779e-2 |
GO:0043484 | regulation of RNA splicing | 2.883660e-2 |
GO:0010424 | DNA methylation on cytosine within a CG sequence | 2.885217e-2 |
GO:0046600 | negative regulation of centriole replication | 2.931478e-2 |
GO:0000076 | DNA replication checkpoint | 2.931478e-2 |
GO:0006668 | sphinganine-1-phosphate metabolic process | 2.931478e-2 |
GO:0033057 | multicellular organismal reproductive behavior | 2.941963e-2 |
GO:0016573 | histone acetylation | 2.999335e-2 |
GO:0035066 | positive regulation of histone acetylation | 3.004494e-2 |
GO:0021532 | neural tube patterning | 3.006014e-2 |
GO:0071044 | histone mRNA catabolic process | 3.029715e-2 |
GO:0030433 | ER-associated protein catabolic process | 3.066155e-2 |
GO:0000042 | protein targeting to Golgi | 3.094567e-2 |
GO:0001302 | replicative cell aging | 3.151614e-2 |
GO:0048026 | positive regulation of nuclear mRNA splicing, via spliceosome | 3.151614e-2 |
GO:0060534 | trachea cartilage development | 3.185021e-2 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 3.185021e-2 |
GO:0042360 | vitamin E metabolic process | 3.186223e-2 |
GO:0072134 | nephrogenic mesenchyme morphogenesis | 3.186223e-2 |
GO:0060764 | cell-cell signaling involved in mammary gland development | 3.186223e-2 |
GO:0034314 | Arp2/3 complex-mediated actin nucleation | 3.186223e-2 |
GO:0008611 | ether lipid biosynthetic process | 3.186223e-2 |
GO:0032342 | aldosterone biosynthetic process | 3.186223e-2 |
GO:0060458 | right lung development | 3.190224e-2 |
GO:0051176 | positive regulation of sulfur metabolic process | 3.190224e-2 |
GO:0044320 | cellular response to leptin stimulus | 3.190224e-2 |
GO:0019348 | dolichol metabolic process | 3.190224e-2 |
GO:0031497 | chromatin assembly | 3.227094e-2 |
GO:0021819 | layer formation in cerebral cortex | 3.247217e-2 |
GO:0050951 | sensory perception of temperature stimulus | 3.247217e-2 |
GO:0010002 | cardioblast differentiation | 3.247217e-2 |
GO:0000239 | pachytene | 3.247217e-2 |